Total Voting Rights

Summary by AI ^BETAClose X

The Sage Group plc. announced that as of 27 February 2026, its issued share capital comprises 993,890,273 ordinary shares, with 55,152,069 shares held in treasury and 7,300,968 shares in the Employee Benefit Trust. Consequently, the total number of exercisable voting rights is 938,738,204, which shareholders should use as the denominator for calculating any notification requirements under the Disclosure and Transparency Rules.

Disclaimer*

Sage Group PLC (The)

27 February 2026

TOTAL VOTING RIGHTS

The Sage Group plc.

27 February 2026

The Sage Group plc. ("Sage"), in conformity with rule 5.6.1 of the Financial Conduct Authority's Disclosure and Transparency Rules (the "DTRs"), announces that, as at 27 February 2026, its issued share capital consists of 993,890,273 ordinary shares of 1^4/77 pence each, of which 55,152,069 ordinary shares of 1^4/77 pence each are held in treasury and 7,300,968 ordinary shares of 1^4/77 pence each are held in The Sage Group plc. Employee Benefit Trust.

Therefore, the total exercisable voting rights in Sage as at 27 February 2026 are 938,738,204.

The above figure of 938,738,204 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Sage under the DTRs.

END

Name of contact:	Mohor Roy
Telephone number of contact:	+44(0) 203 810 7200

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END